Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the most commonly reported side effects of semaglutide, recorded in clinical trials and confirmed in the NHS patient information for this medicine. In the STEP 1 trial, published in the New England Journal of Medicine, gastrointestinal events including diarrhoea occurred more frequently in the semaglutide group than in the placebo group, though most were mild to moderate in severity and time-limited. Wegovy is a prescription-only medicine; a clinical assessment is required before it is prescribed, and a prescriber reviews suitability and likely side effects as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP programme enrolled thousands of adults with obesity across multiple countries, generating a large, well-characterised safety dataset. Across those trials, diarrhoea was among the top reported gastrointestinal effects of semaglutide 2.4 mg, the maintenance dose in Wegovy. The NHS medicines page for semaglutide lists diarrhoea as a common side effect, meaning it affects between one in ten and one in a hundred people taking it, though real-world rates from trial data suggest it is reported by a notably higher proportion during dose escalation phases.
The underlying mechanism is not coincidental. Semaglutide slows gastric emptying and alters gut motility, two effects that reduce appetite but can also disrupt the normal pace of digestion. Some people find that food and fluid move through the intestine more quickly at certain points in the titration schedule, producing loose or frequent stools, and our page on how Wegovy diarrhea tends to develop and resolve explains this process in more detail. This is most noticeable in the days following a dose step-up, when the gut is adjusting to a higher level of GLP-1 receptor stimulation.
For most people, the pattern is predictable: symptoms peak in the first week or two after a new dose, then settle. Eating smaller portions, avoiding high-fat meals, and staying well hydrated tend to ease things. Keeping your Wegovy pen in the fridge and injecting on the same day each week, as directed, helps maintain steady drug levels rather than inadvertent gaps followed by a relative surge.
Most episodes are uncomfortable rather than dangerous. But there are situations that need prompt assessment. If you are dealing with sickness and diarrhoea on Wegovy that is severe, meaning many episodes in a day, or that persists beyond a week or two without improvement, speak to your prescriber or a healthcare professional. Significant diarrhoea combined with repeated vomiting can cause dehydration quickly, and the kidneys are vulnerable when fluid intake falls and losses rise. Signs of dehydration include a dry mouth, dark urine, dizziness, and marked fatigue.
Seek urgent medical help if you develop severe, persistent abdominal pain, particularly pain that radiates toward the back. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines; persistent stomach pain is the key warning sign and should not be attributed to routine GI upset without proper assessment. MHRA Drug Safety Updates are published online and are searchable by medicine name.
Bloody diarrhoea is not expected with semaglutide and always warrants same-day medical contact. If you suspect a side effect is serious or unexpected, it can be reported to the MHRA via the Yellow Card scheme, patients can do this directly, not just healthcare professionals. Our page on known side effects of Wegovy covers the wider safety picture in detail.
There is no single intervention that eliminates GI side effects for everyone, but a consistent pattern of adjustments helps most people manage them. Smaller, lower-fat meals are the most reliably useful change, semaglutide already reduces appetite, so portion sizes often fall naturally, and that itself tends to reduce gut load. Fatty or fried foods appear to worsen nausea and loose stools disproportionately.
Hydration matters more than usual during episodes. Plain water, diluted squash, or an oral rehydration solution replaces both fluid and electrolytes lost through diarrhoea. Caffeine and alcohol can each accelerate gut motility, so reducing them during a flare is sensible. If you want a closer look at how Wegovy side effects related to diarrhea can be managed day to day, including when to consider over-the-counter options such as loperamide, our dedicated page covers that in full, though you should always check with your pharmacist or prescriber before using it routinely alongside a prescription medicine.
Some people find that the full range of Wegovy side effects settles significantly once they reach their maintenance dose and the titration phase is complete. That can take several months, and it is worth discussing ongoing symptoms with your prescriber rather than stopping treatment unilaterally, abrupt discontinuation removes any benefit and the side-effect adjustment period would repeat if treatment is restarted. If you have questions about your experience on treatment, our support team is available seven days a week.
Because gastrointestinal side effects are predictable with semaglutide, a thorough consultation includes discussing your gut history. Conditions such as inflammatory bowel disease, irritable bowel syndrome, or a history of significant GI surgery are factors a prescriber weighs carefully. This is one reason why Wegovy is a prescription-only medicine, the clinical picture, not just the BMI, determines whether it is appropriate for a given individual.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives. A real clinician reviews your answers, considers your medical history, and decides on suitability before anything is dispensed. If Wegovy is clinically suitable for you, you can read more about the treatment itself on our Wegovy overview page, or explore all available weight-loss options at our treatment overview. To discuss your situation with our prescribers, start your free consultation, side effects, including what to expect with your gut, are part of every conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.